Clitocine enhances the drug sensitivity of colon cancer cells by promoting FBXW7-mediated MCL-1 degradation via inhibiting the A2B/cAMP/ERK axis
American Journal of Physiology-Cell Physiology · 2024
DOI: 10.1152/ajpcell.00310.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2024. Verfasst von Feng Ruan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People's Republic of China. Hauptthemen laut MEDLINE: F-Box-WD Repeat-Containing Protein 7, Myeloid Cell Leukemia Sequence 1 Protein, Colonic Neoplasms, Cyclic AMP. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), the Foundation of Taizhou University for Outstanding Young Scientists, Foundation of Taizhou University for Outstanding Young Scientists.
Abstract (Originalsprache)
Our study found that clitocine enhances the drug sensitivity of colon cancer cells by promoting FBXW7-mediated MCL-1 degradation via inhibiting the A2B/cAMP/ERK axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
- Precision Medicine Center, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, People's Republic of China.
- Department of Pathology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, People's Republic of China.
ORCID-Profile: Jianguo Sun
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- the Foundation of Taizhou University for Outstanding Young Scientists
- Foundation of Taizhou University for Outstanding Young Scientists
Zitieren
APA
Ruan, F., Ruan, Y., Gu, H., Sun, J., & Chen, Q. (2024). Clitocine enhances the drug sensitivity of colon cancer cells by promoting FBXW7-mediated MCL-1 degradation via inhibiting the A2B/cAMP/ERK axis. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00310.2024
Vancouver
Ruan F, Ruan Y, Gu H, Sun J, Chen Q. Clitocine enhances the drug sensitivity of colon cancer cells by promoting FBXW7-mediated MCL-1 degradation via inhibiting the A2B/cAMP/ERK axis. American Journal of Physiology-Cell Physiology. 2024. doi:10.1152/ajpcell.00310.2024
BibTeX
@article{Ruan2024,
author = {Ruan, Feng and Ruan, Yanyun and Gu, Huamin and Sun, Jianguo and Chen, Qi},
title = {Clitocine enhances the drug sensitivity of colon cancer cells by promoting FBXW7-mediated MCL-1 degradation via inhibiting the A2B/cAMP/ERK axis},
journal = {American Journal of Physiology-Cell Physiology},
year = {2024},
doi = {10.1152/ajpcell.00310.2024}
}
EUVIMED